Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 25658 | 228 | 40.4 | 92% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2836 | 2461 | PRADER WILLI SYNDROME//ANGELMAN SYNDROME//PAR 4 |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PAR 4 | Author keyword | 63 | 64% | 27% | 62 |
| 2 | AATF | Author keyword | 11 | 78% | 3% | 7 |
| 3 | PROSTATE APOPTOSIS RESPONSE 4 | Author keyword | 7 | 64% | 3% | 7 |
| 4 | MIR 2909 | Author keyword | 6 | 80% | 2% | 4 |
| 5 | LP MARKEY CANC | Address | 6 | 50% | 4% | 8 |
| 6 | THER EUT PROGRAMS DEV | Address | 5 | 63% | 2% | 5 |
| 7 | AATF CHE 1 | Author keyword | 3 | 100% | 1% | 3 |
| 8 | PHLDA1 | Author keyword | 3 | 38% | 3% | 6 |
| 9 | ROME ONCOGENOM | Address | 2 | 33% | 3% | 6 |
| 10 | PROSTATE APOPTOSIS RESPONSE FACTOR 4 | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PAR 4 | 63 | 64% | 27% | 62 | Search PAR+4 | Search PAR+4 |
| 2 | AATF | 11 | 78% | 3% | 7 | Search AATF | Search AATF |
| 3 | PROSTATE APOPTOSIS RESPONSE 4 | 7 | 64% | 3% | 7 | Search PROSTATE+APOPTOSIS+RESPONSE+4 | Search PROSTATE+APOPTOSIS+RESPONSE+4 |
| 4 | MIR 2909 | 6 | 80% | 2% | 4 | Search MIR+2909 | Search MIR+2909 |
| 5 | AATF CHE 1 | 3 | 100% | 1% | 3 | Search AATF+CHE+1 | Search AATF+CHE+1 |
| 6 | PHLDA1 | 3 | 38% | 3% | 6 | Search PHLDA1 | Search PHLDA1 |
| 7 | PROSTATE APOPTOSIS RESPONSE FACTOR 4 | 2 | 67% | 1% | 2 | Search PROSTATE+APOPTOSIS+RESPONSE+FACTOR+4 | Search PROSTATE+APOPTOSIS+RESPONSE+FACTOR+4 |
| 8 | CHE 1 | 2 | 40% | 2% | 4 | Search CHE+1 | Search CHE+1 |
| 9 | TDAG51 | 2 | 43% | 1% | 3 | Search TDAG51 | Search TDAG51 |
| 10 | AATF RNOME | 1 | 100% | 1% | 2 | Search AATF+RNOME | Search AATF+RNOME |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROTEIN PAR 4 | 44 | 78% | 13% | 29 |
| 2 | TUMOR SUPPRESSOR PAR 4 | 29 | 88% | 6% | 14 |
| 3 | PAR 4 | 9 | 37% | 9% | 20 |
| 4 | ZIPPER PROTEIN PAR 4 | 8 | 70% | 3% | 7 |
| 5 | CHE 1 | 7 | 67% | 3% | 6 |
| 6 | PROSTATE APOPTOSIS | 6 | 71% | 2% | 5 |
| 7 | TDAG51 | 5 | 50% | 3% | 7 |
| 8 | DLK ZIP KINASE | 5 | 37% | 4% | 10 |
| 9 | APOPTOTIC PROTEIN PAR 4 | 3 | 100% | 1% | 3 |
| 10 | SUPPRESSOR PAR 4 | 3 | 100% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Cancer-selective apoptotic effects of extracellular and intracellular Par-4 | 2010 | 27 | 46 | 59% |
| The phosphoinositide 3-kinase/Akt1/Par-4 axis: A cancer-selective therapeutic target | 2006 | 61 | 19 | 68% |
| Par-4 as a potential target for cancer therapy | 2013 | 4 | 86 | 58% |
| Mechanisms of apoptosis by the tumor suppressor Par-4 | 2012 | 11 | 47 | 47% |
| Apoptosis and tumor resistance conferred by Par-4 | 2008 | 17 | 73 | 37% |
| PAR-4 as a possible new target for pancreatic cancer therapy | 2010 | 8 | 81 | 31% |
| Expression and function of prostate-apoptosis-response gene-4 in lymphatic cells | 2002 | 3 | 16 | 75% |
| Cellular AATF gene: Armour against HIV-1 | 2007 | 1 | 12 | 58% |
| Intrinsic disorder and coiled-coil formation in prostate apoptosis response factor 4 | 2009 | 8 | 102 | 31% |
| PAR-4: a possible new target for age-related disease | 2014 | 0 | 83 | 42% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LP MARKEY CANC | 6 | 50% | 3.5% | 8 |
| 2 | THER EUT PROGRAMS DEV | 5 | 63% | 2.2% | 5 |
| 3 | ROME ONCOGENOM | 2 | 33% | 2.6% | 6 |
| 4 | GRC 4F01 | 1 | 50% | 0.4% | 1 |
| 5 | OIO PESQUISA | 1 | 50% | 0.4% | 1 |
| 6 | PROT FOLDING DIS INITIAT | 1 | 50% | 0.4% | 1 |
| 7 | SYST BIOL AGING | 1 | 50% | 0.4% | 1 |
| 8 | UROL MICROBIOL IMMUNOL | 1 | 50% | 0.4% | 1 |
| 9 | MRC BIOREACT ROS | 0 | 33% | 0.4% | 1 |
| 10 | PHYSIOL ENDOCRINE SYST | 0 | 33% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000261765 | DAP KINASE//DEATH ASSOCIATED PROTEIN KINASE//DAPK |
| 2 | 0.0000095114 | NEUROONTOGENESIS//JCASP//FUNCT BIOCHEM NERVOUS SYST |
| 3 | 0.0000074817 | NECDIN//REGULAT MACROMOL FUNCT//REGULAT NEURONAL DEV |
| 4 | 0.0000069629 | GRP78//BIOCHEM PROTE GRP//GLUCOSE REGULATED PROTEIN 78 |
| 5 | 0.0000062429 | CRUMBS//L2GL//ERBIN |
| 6 | 0.0000054464 | HIPK2//CACYBP SIP//CACYBP |
| 7 | 0.0000050632 | AMMODYTES PERSONATUS//SAND LANCE//CATCH FORECASTING |
| 8 | 0.0000046785 | REV EXPORT INHIBITOR//CALLYSTATIN A//CRM1 INHIBITOR |
| 9 | 0.0000039739 | BCL10//PKC THETA//CARMA3 |
| 10 | 0.0000036681 | FAT10//MALLORY BODY//MALLORY DENK BODIES MDBS |